- The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers
-
Ngoi NY, Tan DS
- KMID: 2457146
- J Gynecol Oncol.
- 2019 Mar;30(2):e48.
- doi: 10.3802/jgo.2019.30.e48
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
-
Lee MX, Tan DS
- KMID: 2431241
- J Gynecol Oncol.
- 2018 Nov;29(6):e96.
- doi: 10.3802/jgo.2018.29.e96
The 3-weekly regimen of carboplatin and paclitaxel is the backbone of first line adjuvant chemotherapy for advanced ovarian cancer. The landmark Japanese Gynaecologic Oncology Group (JGOG) 3016 study demonstrated significant... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on immune checkpoint inhibitors in gynecological cancers
-
Heong V, Ngoi N, Tan DS
- KMID: 2413459
- J Gynecol Oncol.
- 2017 Mar;28(2):e20.
- doi: 10.3802/jgo.2017.28.e20
In recent years, progress in our understanding of immune-modulatory signaling pathways in immune cells and the tumor microenvironment (TME) has led to rejuvenated interest in cancer immunotherapy. In particular, immunotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
-
Lee YJ, Lim MC, Kim BG, Ngoi NY, Choi CH, Park SY, Tan DS, Go Y, Lee JY
- KMID: 2526377
- J Gynecol Oncol.
- 2021 Mar;32(2):e31.
- doi: 10.3802/jgo.2021.32.e31
Background: The optimal treatment of BRCA wild-type patients with platinum-sensitive recurrent ovarian cancer remains unknown. Recently, there is an increase in the evidence to support the role of the combination... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
-
Tan DS, Chan JJ, Hettle R, Ghosh W, Viswambaram A, Yu CC
- KMID: 2526375
- J Gynecol Oncol.
- 2021 Mar;32(2):e27.
- doi: 10.3802/jgo.2021.32.e27
Objective: To evaluate the cost-effectiveness of olaparib as a maintenance treatment versus routine surveillance (RS) in patients with BRCA mutated (BRCAm) advanced ovarian cancer (OC) following response to first-line platinum-based... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Society of Gynecologic Oncology International Workshop 2018
-
Kong TW, Ryu HS, Kim SC, Enomoto T, Li J, Kim KH, Shim SH, Wang PH, Therasakvichya S, Kobayashi , Lee M, Shi T, Lee SW, Mikami M, Nagase S, Lim MC, Wang J, Wilailak S, Kim SW, Hong SH, Tan DS, Mandai M, Chang SJ, Huang RY, Ushijima K, Lee JY, Chen X, Ochiai K, Lee TS, Yang B, Kalam F, Lv Q, Ahmad MF, Yaznil MR, Modi KB, Manopunya , Jeong DH, Lertkhachonsuk Aa, Chung HH, Watari H, Jeon S
- KMID: 2457142
- J Gynecol Oncol.
- 2019 Mar;30(2):e39.
- doi: 10.3802/jgo.2019.30.e39
The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to 25th August 2018. The workshop... -
- CITED
-
- Close
- SHARE
-
- Close
